Regulating in the Name of Public Health

Mitch Zeller served as director of FDA’s Center for Tobacco Products from 2013 to 2022. Zeller has worked to reduce tobacco-related harm through evidence-based regulation. The path to regulatory success is riddled with uncertainty, Zeller says. “The more impactful a public health policy, the longer it is likely to take to see it go into effect. At some point, the time will be right,” he says. He currently advises the start-up pharmaceutical company Qnovia, which is developing an inhalable smoking cessation product. The Regulatory Review spoke with Zeller about his tenure at the U.S. Food and Drug Administration (FDA) and how lessons from tobacco regulation can be applied to broader health policymaking. The full interview is available on www.theregulatoryreview.com. For confidential support, call the National Suicide Prevention Lifeline at 1-800-273-8255 or visit http://www.suicidepreventionlifeline.org/.

Source: Theregreview.org  |  Read full article